The platform will undergo maintenance on Sep 14 at about 9:30 AM EST and will be unavailable for approximately 1 hour.
2009
DOI: 10.1016/j.ijantimicag.2009.04.005
|View full text |Cite
|
Sign up to set email alerts
|

In vitro and ex vivo activity of peptide deformylase inhibitors against Mycobacterium tuberculosis H37Rv

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
13
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 18 publications
(14 citation statements)
references
References 38 publications
1
13
0
Order By: Relevance
“…NHF165 exhibited the highest activity against V. anguillarum , and the functional component was finally determined as actinonin. Actinonin was isolated from soil Streptomyces in 1962 and was reported to be an inhibitor targeting E. coli PDF and M. tuberculosis PDF ( Sharma et al, 2009 ). Our discovery is the first report to show that marine derived actinonin possesses anti- Vibrio activity via targeting VaPDF.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…NHF165 exhibited the highest activity against V. anguillarum , and the functional component was finally determined as actinonin. Actinonin was isolated from soil Streptomyces in 1962 and was reported to be an inhibitor targeting E. coli PDF and M. tuberculosis PDF ( Sharma et al, 2009 ). Our discovery is the first report to show that marine derived actinonin possesses anti- Vibrio activity via targeting VaPDF.…”
Section: Discussionmentioning
confidence: 99%
“…The widespread occurrence, conservation, and essential nature of deformylase in bacteria make it an attractive target for antibacterial drug discovery ( Giglione et al, 2000 ; Sangshetti et al, 2015 ). PDF is widely used in human bacteria infection treatment caused by Staphylococcus aureus, Streptococcus pneumonia, Helicobacter pylori , Haemophilus influenza and Mycobacterium tuberculosis , etc ( Sharma et al, 2009 ; Peyrusson et al, 2015 ). PDF inhibitors, GSK-1322322, BB-83698 and LBM-415, have entered into clinical developments ( Sangshetti et al, 2015 ).…”
Section: Introductionmentioning
confidence: 99%
“…Molecular docking has been used for the screening of potent drug molecules by targeting the aerolysin of A. hydrophila [38] and 3-oxoacyl-acyl carrier protein synthase II of Mycobacterium tuberculosis [56]. Sharma et al [57] have tested BB-3497 and actinonin and both were found to be potent drugs against the PDF of M. tuberculosis at low concentrations. While in the case of interaction of a BBS-02 molecule with PDF, a number of amino acids including Tyr39, Ile45, Gly46, Gln51, Leu92, His137, Glu134, Cys91, Gly90, Ile120, and Leu92 were obtained (Figure 5a).…”
Section: Screening Of Potent Drugs and Phylogenetic Analysismentioning
confidence: 99%
“…[32,33] 1,10-Phenanthroline has been found active against Mycobacterium tuberculosis. [34] Tuberculosis is a well-known disease that has troubled human beings in past times [35] and still remains a major health problem. The World Health Organization (WHO) estimates that one-third of the population is infected with latent Mycobacterium tuberculosis and approximately 3 million people per year die due to this bacillus.…”
Section: Introductionmentioning
confidence: 99%